Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the second quarter of 2023 on Tuesday, August 8, 2023, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah’s Q2 2023 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Nyxoah’s Q2 2023 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000831970

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TriplePoint Venture Growth BDC Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TPVG

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) between March 4, 2020 and May 1, 2023, both dates inclusive (the “Class Period”), of the important August 15, 2023 lead plaintiff deadline.

SO WHAT: If you purchased TriplePoint securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the TriplePoint class action, go to https://rosenlegal.com/submit-form/?case_id=15759 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 15, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose, among other things, that: (1) TriplePoint had overstated the strength of its various portfolio companies and loan book, as well as the viability of its overall investment strategy; (2) the foregoing, once revealed, was likely to have a material negative impact on the Company’s financial position and/or prospects; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the TriplePoint class action, go to https://rosenlegal.com/submit-form/?case_id=15759 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8882219

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Canaccord Genuity 43rd Growth Conference, which takes place August 7 – 10, 2023 in Boston, Massachusetts.

Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver a corporate update on Wednesday, August 9, 2023, at 9:30am EST. A webcast of the presentation will be available on the Events section of Nyxoah’s Investor Relations website. The Company will also be available for 1×1 meetings with institutional investors attending the event.

Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000831969

UAE urges G20 nations to demonstrate solidarity on climate action

With only 124 days left before COP28 UAE, COP President-Designate Dr. Sultan Al Jaber today urged G20 nations to take a leadership role on climate action, and said that their decisions will have an enormous influence on the outcomes for all countries.

In a speech at the G20 Climate Sustainability Ministerial Meeting in Chennai, India, Dr. Al Jaber expressed his concern that his call at last week’s meeting in Goa to triple renewable energy capacity by 2030 has “yet to find expression in G20 outcomes,” despite its importance to the goal of keeping 1.5C within reach, Emirates News Agency (WAM) reported.

“As a group, the G20 represents 85 per cent of the world’s GDP and 80 per cent of the world’s emissions. What you decide will have a huge influence on outcomes for everyone, everywhere,” Dr. Al Jaber told ministers. “There is still time for the G20 to show leadership, and I am calling on all of you to work with your leaders to drive global climate action in this critical decade.”

“Yesterday we issued a joint statement with UNFCCC Executive Secretary Simon Stiell, calling on the G20 to show leadership in closing the gaps across all of the pillars of the Paris Agreement and help the world get on track to keep 1.5C within reach.”

Dr. Al Jaber also called on all parties to show solidarity and demonstrate commitment to the UN Secretary General’s Climate Solidarity Pact and Acceleration Agenda.

“I made the case for all parties to get behind a rapid scale up of renewable energy, while we comprehensively decarbonise the current energy system and build towards a system free of all unabated fossil fuels,” added Dr. Al Jaber.

The President-Designate also highlighted the importance of making progress on adaptation, with parties having signed up to the Global Goal on Adaptation under the Paris Agreement.

“We all signed up to this. We are all responsible for its success,” he said. “Yet today, the science and our senses are telling us that the world is more vulnerable, less resilient and lacks the critical capacity to deal with mounting climate impacts.”

Dr. Al Jaber added, “Right now, many of the indicators are going in the wrong direction. Temperature records continue to be broken, with this month officially recorded as the hottest in history. We are losing biodiversity. Agricultural land is being degraded. And food insecurity is increasing.”

The COP28 Presidency is urging nations to accelerate the implementation of ‘30×30’ – the target to conserve 30 percent of terrestrial and marine habitat by the end of this decade – and is also calling for expansion of the Forest and Climate Leaders Partnership, Dr. Al Jaber said.

“If we are going to make progress on adaptation, we first have to define what success looks like in terms of stopping biodiversity loss, restoring agricultural land, preserving forests, protecting coastlines, ensuring no-one goes hungry and safeguarding lives and livelihoods everywhere,” he said.

Transformation of food systems is also a top priority for the COP28 Presidency – “and we need it to be your priority as well,” he told ministers. “Your national adaptation plans and strategies should promote sustainable land use, leverage technologies to increase crop resilience, enhance nutrition and reduce the climate impacts of farming.”

COP28 will be the first edition of the conference to explicitly link climate impacts to global health, with a day dedicated to health issues, and the first-ever climate health ministerial in partnership with the World Health Organisation. The President-Designate invited all G20 nations to partner on this to ensure the resilience of global health systems.

The President-Designate reiterated the need to “move the needle on adaptation finance” which is only around 10 percent of that allocated for mitigation.

“Doubling adaptation finance by 2025 is a critical first step but we need to look at directing a solid proportion of all climate finance toward adaptation responses,” he said. “The more that is invested in adaptation, the greater our collective resilience to climate impacts will be.”

Dr. Al Jaber added, “Yet we must acknowledge that many vulnerable countries- in particular small island developing states and least developed countries- are already experiencing consequences of climate change that go beyond what people can adapt to.”

Concluding his remarks, Dr. Al Jaber said, “Every day we are seeing the human impacts of extreme climate events devastating the lives of ordinary people around the world. Let us reflect on that as human beings and remember once again why solidarity is so important. I urge you to bring that spirit of solidarity to COP28.”

Source: Bahrain News Agency

Mass rally in Hajjah commemorating Ashura

Hajjah province witnessed a mass rally on the day of “Ashura” the commemoration of the martyrdom of Imam Hussein, peace be upon him.

The participants in the march emphasized the importance of commemorating Ashura, in order to recall the tragedy that occurred during it, represented in the murder of Imam Hussein, peace be upon him.

The crowds considered the commemoration as one of the expressions of love, loyalty, and attachment to the Master of Martyrs, and an expression of attachment to the Qur’anic approach and vision.

It referred to the decisiveness of the choice and the decision to adhere to Islam, which liberates people from every tyrant and juggernaut.

Source: Yemen News Agency

Mass rally in Bayda commemorating Ashura

Bayda province witnessed a massive mass march to commemorate “Ashura”, condemning and rejecting the crime of burning the Holy Quran in Sweden and Denmark.

The participants in the march denounced the repeated crimes of burning copies of the Noble Qur’an and attacking Islamic sanctities and symbols.

The mass crowds responded with cheers affirming loyalty to the revolution of Imam Hussein, peace be upon him, the grandson of the Messenger of God, and rejecting the persistence of the forces of hegemony and arrogance and the targeting of Islamic sanctities.

Source: Yemen News Agency